Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The pediatric OCD treatment study (POTS) randomized controlled trial

JAMA

Volumn 292, Issue 16, 2004, Pages 1969-1976

  March, John S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; APPETITE DISORDER; ARTICLE; BEHAVIOR THERAPY; CHILD; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENURESIS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK BENEFIT ANALYSIS; SIDE EFFECT; STOMACH PAIN; TREATMENT OUTCOME;

EID: 6944229468     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.16.1969     Document Type: Article

References (33)

1. Flament MF, Whitaker A, Rapoport JL, et al. Obsessive-compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988;27:764-771.
2. DeVeaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder-a multicenter trial. J Am Acad Child Adolesc Psychiatry. 1992;31:45-49.
3. Riddle MA, Reeve EA, Yaryura-Tobias JA, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. 2001;40:222-229.
4. March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA. 1998;280:1752-1756.
5. Geller DA, Hoog SL, Heiligenstein JH, et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry. 2001;40:773-779.
6. Geller DA, Biederman J, Stewart SE, et al. Which SSRI? a meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003;160:1919-1928.
7. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry. 1995;52:53-60.
8. Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol. 2000;68:594-602.
9. March JS, Mulle K, Herbei B. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. J Am Acad Child Adolesc Psychiatry. 1994;33:333-341.
10. Franklin ME, Kozak MJ, Cashman LA, Coles ME, Rheingold AA, Foa EB. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry. 1998;37:412-419.
11. de Haan E, Hoogduin C. The treatment of children with obsessive-compulsive disorder. Acta Paedopsychiatr. 1992;55:93-97.
12. Franklin M, Foa E, March JS. The Pediatric Obsessive-Compulsive Disorder Treatment Study: rationale, design, and methods. J Child Adolesc Psychopharmacol. 2003;13(suppl 1):S39-S51.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
14. Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive-Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844-852.
15. Silverman W, Albano A. The Anxiety Disorders Interview Schedule for DSM-IV, Child and Parent Versions. San Antonio, Tex: The Psychological Corp; 1996.
16. Goodman WK, Price LH. Assessment of severity and change in obsessive compulsive disorder. Psychiatr Clin North Am. 1992;15:861-869.
17. Wechsler D. Wechsler Intelligence Scale for Children. San Antonio, Tex: The Psychological Corp; 1991.
18. Pocock S. Clinical Trials: A Practical Approach. New York, NY: Wiley/Liss; 1983.
19. Berger VW, Exner DV. Detecting selection bias in randomized clinical trials. Control Clin Trials. 1999; 20:319-327.
20. March J, Mulle K. OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual. New York, NY: Guilford Press; 1998.
21. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(suppl 10):27-45.
22. Franklin ME, Rynn M, March JS, Foa EB. Obsessive-compulsive disorder. In: Hersen M1 ed. Clinical Behavior Therapy: Adults and Children. New York, NY: John Wiley & Sons Inc; 2002:276-303.
23. Weinfert K. Repeated-measures analyses: ANOVA, MANOVA, HLM. In: Grimm L, Yarnold P, eds. Reading and Understanding More Multivariate Statistics. Washington, DC: American Psychological Press; 2000: 317-362.
24. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61:310-317.
25. Rosenthal R, Rosnow R, Rubin DB. Contrasts and effect Sizes in Behavioral Research. Cambridge, England: Cambridge University Press; 2000.
26. Sackett D, Richardson W, Rosenberg W, Haynes B. Evidence-Based Medicine. 2nd ed. London, England: Churchill Livingston; 2000.
27. Geller D, Biederman J, Faraone SV, et al. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety. 2000;11: 163-168.
28. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59: 877-883.
29. Vitiello B, Swedo S. Antidepressant medications in children. N Engl J Med. 2004;350:1489-1491.
30. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363:1341-1345.
31. Schoenwald SK, Hoagwood K. Effectiveness, transportability, and dissemination of interventions: what matters when? Psychiatr Serv. 2001;52:1190-1197.
32. Barlow DH, Levitt JT, Bufka LF. The dissemination of empirically supported treatments: a view to the future. Behav Res Ther. 1999;(suppl 1):S147-S162.
33. March J, Frances A, Kahn D, Carpenter D. Expert Consensus Guidelines: Treatment of Obsessive-Compulsive Disorder. J Clin Psychiatry. 1997;58(suppl 4):1-72.